From July 1, 2012 to September 30, 2012, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 37,530,000 shares, representing 1.64% for $2,293.58 million under the buyback announced on December 15, 2010.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
97.11 CHF | +0.52% |
|
+0.53% | +14.56% |
05/07 | Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code | MT |
05/07 | UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.56% | 220B | |
+56.89% | 823B | |
+40.32% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+14.15% | 239B | |
-0.25% | 219B | |
+7.94% | 167B | |
-2.57% | 159B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Tranche Update on Novartis AG's Equity Buyback Plan announced on December 15, 2010.